Quan Capital Management, LLC

About

Healthcare-focused global venture capital firm in China | Quan Capital We are Company Builders Identifying, incubating and growing future industry leaders in life sciences. We are Industry Veterans Capturing evolving healthcare trends and emerging cutting-edge innovations We are Preferred Partners Connecting companies with extensive network and resources globally and in China Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long- Acting Anti-TSLP Antibody WIN378 ... June 9, 2026 OriCell s GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma ... June 8, 2026 China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer ... June 8, 2026 All news About Us | Quan Capital About Us Introduction Just like our name “Quan” (meaning “Fountain／Spring” in Chinese), we discover, incubate and grow next-generation life sciences companies. Our unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Our portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significant value to patients. In addition, we are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China. Empowered by strong expertise in both science and business, our inves

Key Contact